Pregnant women with autoimmune conditions at a greater risk of developing adverse pregnancy outcomes, study suggests

FHS
March 8, 2024
1:20 pm

Researchers analyzed systematic reviews conducted on the association between autoimmune diseases and pregnancy outcomes.

Charité and Samsung Comprehensive Cancer Center partner to advance cancer medicine

Charité – Universitätsmedizin Berlin and the Samsung Comprehensive Cancer Center in Seoul have signed a memorandum of understanding.

July 31, 2023

Kaempferol boosts immune tolerance and fights allergies

Kaempferol’s role in Treg development is linked to Aldh1a2 activation in dendritic cells, highlighting its potential in suppressing inflammation and allergies.

December 19, 2024

Clinigen clears out cancer therapies in line with latest growth strategy – Pharmaceutical Technology

This action follows Clinigen’s January 2023 sale of its kidney cancer treatment Proleukin (aldesleukin) to Iovance Biotherapeutics. Credit: Volodymyr Maksymchuk via Shutterstock. UK-headquartered Clinigen announced

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.